Patent assignee · KR · COMPANY

GENEXINE, INC.

28Patents
25Active
28Granted
48Portfolio score

Filing activity: Dec 6, 2000 → Nov 8, 2022 · 4 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US7867491B2 Immunoglobulin fusion proteins Chemistry; Metallurgy 19 Active
US8883134B2 Human interleukin-1 receptor antagonist—hybrid Fc fusion protein Chemistry; Metallurgy 17 Active
US7910564B2 Genes of IL-12P40 subunit mutated for improving the activity of IL-12 and use thereof for DNA vaccine adjuvant Emerging Cross-Sectional Technologies 7 Active
US8586038B2 Chimeric immunoglobulin fusion proteins Chemistry; Metallurgy 7 Active
US10208099B2 Modified interleukin-7 protein Chemistry; Metallurgy 5 Active
US8137674B2 Compositions comprising HPV polypeptides and immunoenhancement peptides for the treatment and prevention of cervical cancer Chemistry; Metallurgy 5 Active
US9000139B2 Composition for preventing or treating cervical cancer having human papillomavirus plasmodium and immunity enhancer Emerging Cross-Sectional Technologies 3 Active
US8529899B2 Human growth hormone immunoglobulin fusion proteins Chemistry; Metallurgy 2 Active
US9399665B2 Composition for preventing or treating cervical cancer having human papillomavirus plasmodium and immunity enhancer Emerging Cross-Sectional Technologies 2 Active
US10844104B2 Modified interleukin-7 protein Chemistry; Metallurgy 2 Active
US8586048B2 G-CSF immunoglobulin fusion proteins Chemistry; Metallurgy 2 Active
US11135262B2 Methods of treating cervical cancer Chemistry; Metallurgy 2 Active
US7253151B2 Genes of IL-12P40 subunit mutated for improving the activity of IL-12 and use thereof for DNA vaccine adjuvant Emerging Cross-Sectional Technologies 1 Expired
US11357827B2 Method for preventing or treating influenza virus infection using pharmaceutical composition comprising immunoglobulin Fc-fused interleukin-7 fusion protein Human Necessities 1 Active
US11548927B2 Formulation of modified interleukin-7 fusion protein Chemistry; Metallurgy 1 Active
US10538569B2 Fusion polypeptide containing GLP and immunoglobulin hybrid Fc and use thereof Chemistry; Metallurgy 1 Active
US11708399B2 Pharmaceutical composition comprising immunoglobulin Fc-fused interleukin-7 fusion protein for preventing or treating human papillomavirus-caused diseases Chemistry; Metallurgy 1 Active
US11524054B2 Method of treating anemia using long-acting EPO formulation Chemistry; Metallurgy 0 Active
US8586531B2 Erythropoietin immunoglobulin fusion proteins Chemistry; Metallurgy 0 Active
US12427186B2 Method for treating growth hormone deficiency employing hGH fusion protein Physics 0 Active
US11883479B2 Method for treating cervical cancer Chemistry; Metallurgy 0 Active
US6818442B2 AIDS DNA vaccine that prevents SIVmac239 virus infection in monkeys Chemistry; Metallurgy 0 Expired
US7989425B2 Vaccine enhancing the protective immunity to hepatitis c virus using plasmid DNA and recombinant adenovirus Chemistry; Metallurgy 0 Expired
US12233113B2 Pharmaceutical composition comprising recombinant hGH for the treatment of growth hormone deficiency Human Necessities 0 Active
USRE46453E1 Compositions comprising HPV polypeptides and immunoenhancement peptides for the treatment and prevention of cervical cancer General 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.